All Viruses articles – Page 50
-
NewsDeadly virus structures pinpoint new targets for Lassa vaccine design
By comparing the structures of protein complexes from different lineages of the dangerous Lassa virus, a research team has identified new antibodies and vaccine targets.
-
CareersUnearthing the secrets of living rocks
Working on a NASA-CSA project was a dream come true - and 13 years on, I’ve travelled the world unravelling the secret of contemporary microbialites.
-
NewsKissing down the epochs played role in disease transmission
Romantic kissing was a common practice in ancient times and cannot be regarded as a sudden biological trigger causing a spread of specific pathogens, a new study suggests.
-
OpinionThe threat of viral zoonosis hasn’t gone away
Why we’re liable to be ambushed by viral zoonosis - despite everything we’ve learned from Covid
-
NewsCovid beta variant in Mozambique transmitted through regional migration
A genomic surveillance study in Mozambique reveals that the beta variant of the virus was transmitted through regional migration, and questions the benefits of closing borders.
-
NewsMonkeypox virus remains stable on surfaces for days
Researchers warn that it is extremely important to disinfect surfaces to decrease the risk of monkeypox in the event of an outbreak.
-
NewsEngineered virus with immunotherapy safe and improves cancer outcomes
A new study validates the safety of a combination approach using an engineered virus and immunotherapy to target an aggressive brain cancer, and offers promise to adapt treatment strategies.
-
NewsClinical trial of mRNA universal influenza vaccine candidate begins
A clinical trial of an experimental universal influenza vaccine, H1ssF-3928 mRNA-LNP, has begun enrolling volunteers to test for safety and its ability to induce an immune response.
-
NewsFilamentous phage structure mapped for the first time
Researchers have mapped out what a commonly-used form of phage looks like, which will help researchers design better uses in future.
-
FeaturesA new frontier in Zika vaccine development
A milestone achievement for science in combating the Zika virus as a new vaccine trial begins in the UK.
-
NewsAncestral mitoviruses discovered in mycorrhizal fungi
A new group of mitochondrial viruses confined to the arbuscular mycorrhizal fungi Glomeromycotina may represent an ancestral lineage of mitoviruses.
-
NewsPostal HPV kits boost cervical screening uptake
At-home high-risk human papillomavirus (hrHPV) sampling kits can help increase cervical cancer screening among under-screened women from low-income backgrounds, according to findings from a US-based clinical trial.
-
NewsMeet Ginger: the gene-edited calf resistant to BVDV
Scientists introduce Ginger, the first gene-edited calf with reduced susceptibility to a major viral pathogen.
-
NewsProtein may pave way to eliminating HIV latency
Researchers have identified and characterized Schlafen 12 (SLFN 12) as a novel HIV restriction factor that shuts down viral protein production and helps virus-infected cells to escape from anti-HIV therapy and immune responses.
-
NewsCRISPR-based drug candidate targets the microbiome
Scientists have engineered the first published CRISPR-based candidate for a drug - a combination of phages - that targets E. coli directly and leaves the microbiome intact.
-
NewsViruses may disrupt carbon cycle in warming world
Scientists describe many different ways that increasing temperatures could affect viruses and their microbial hosts, changes that could ultimately affect the responses of whole ecosystems to warming.
-
NewsMeasles surge sparks UK government vaccine call
The UK government has urged parents to make sure their children’s MMR vaccine is up to date following a rise of measles cases.
-
NewsBlack eyes in seabirds indicates bird flu survival
A new study has discovered evidence that Northern Gannets can recover from Highly Pathogenic Avian Influenza (HPAI) H5N1, with black irises indicating a previous infection.
-
NewsLiverpool begins first human trial of Zika vaccine
The first participant has received a dose of a new Zika virus vaccine being trialled by the University of Liverpool.
-
NewsHIV targeted with novel dual gene-editing approach
Gene-editing therapy aimed at two targets – HIV-1, the virus that causes AIDS, and CCR5, the co-receptor that helps the virus get into cells – can effectively eliminate HIV infection, new research shows.